442 related articles for article (PubMed ID: 27506421)
1. The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.
Lisovsky I; Isitman G; Tremblay-McLean A; Song R; DaFonseca S; Lebouchẻ B; Routy JP; Bruneau J; Bernard NF
Clin Exp Immunol; 2016 Dec; 186(3):336-346. PubMed ID: 27506421
[TBL] [Abstract][Full Text] [Related]
2. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.
Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF
J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228
[TBL] [Abstract][Full Text] [Related]
3. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
[TBL] [Abstract][Full Text] [Related]
4. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.
Song R; Lisovsky I; Lebouché B; Routy JP; Bruneau J; Bernard NF
PLoS Pathog; 2014 Jan; 10(1):e1003867. PubMed ID: 24453969
[TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions.
Bernard NF
AIDS Res Ther; 2017 Sep; 14(1):38. PubMed ID: 28893287
[TBL] [Abstract][Full Text] [Related]
6. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
[TBL] [Abstract][Full Text] [Related]
7. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.
Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF
J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.
Lisovsky I; Kant S; Tremblay-McLean A; Isitman G; Kiani Z; Dupuy FP; Gilbert L; Bruneau J; Shoukry NH; Lebouché B; Bernard NF
J Leukoc Biol; 2019 Mar; 105(3):551-563. PubMed ID: 30698860
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
[TBL] [Abstract][Full Text] [Related]
10. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N;
J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of NK cell subsets activated by 721.221 and K562 HLA-null cells.
Lisovsky I; Isitman G; Bruneau J; Bernard NF
J Leukoc Biol; 2015 Apr; 97(4):761-7. PubMed ID: 25713086
[TBL] [Abstract][Full Text] [Related]
12. HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.
Kiani Z; Bruneau J; Geraghty DE; Bernard NF
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270222
[TBL] [Abstract][Full Text] [Related]
13. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
Gooneratne SL; Center RJ; Kent SJ; Parsons MS
Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
[TBL] [Abstract][Full Text] [Related]
14. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
[TBL] [Abstract][Full Text] [Related]
15. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
[TBL] [Abstract][Full Text] [Related]
16. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
[TBL] [Abstract][Full Text] [Related]
17. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.
Isitman G; Tremblay-McLean A; Lisovsky I; Bruneau J; Lebouché B; Routy JP; Bernard NF
PLoS One; 2016; 11(10):e0164517. PubMed ID: 27732638
[TBL] [Abstract][Full Text] [Related]
18. KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.
Thoens C; Berger C; Trippler M; Siemann H; Lutterbeck M; Broering R; Schlaak J; Heinemann FM; Heinold A; Nattermann J; Scherbaum N; Alter G; Timm J
J Hepatol; 2014 Sep; 61(3):475-81. PubMed ID: 24780303
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study.
La D; Czarnecki C; El-Gabalawy H; Kumar A; Meyers AF; Bastien N; Simonsen JN; Plummer FA; Luo M
PLoS One; 2011; 6(12):e29200. PubMed ID: 22216211
[TBL] [Abstract][Full Text] [Related]
20. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
